Workflow
治疗
icon
Search documents
普瑞眼科10月10日获融资买入328.71万元,融资余额7012.85万元
Xin Lang Cai Jing· 2025-10-13 01:33
10月10日,普瑞眼科涨0.87%,成交额5025.76万元。两融数据显示,当日普瑞眼科获融资买入额328.71 万元,融资偿还315.19万元,融资净买入13.52万元。截至10月10日,普瑞眼科融资融券余额合计 7078.43万元。 融资方面,普瑞眼科当日融资买入328.71万元。当前融资余额7012.85万元,占流通市值的1.27%,融资 余额低于近一年10%分位水平,处于低位。 截至6月30日,普瑞眼科股东户数1.06万,较上期增加6.24%;人均流通股6647股,较上期减少5.87%。 2025年1月-6月,普瑞眼科实现营业收入14.59亿元,同比增长2.74%;归母净利润1466.75万元,同比减 少66.12%。 分红方面,普瑞眼科A股上市后累计派现7450.74万元。 机构持仓方面,截止2025年6月30日,普瑞眼科十大流通股东中,融通健康产业灵活配置混合A/B (000727)位居第三大流通股东,持股259.25万股,相比上期增加69.24万股。圆信永丰聚优A (010469)位居第四大流通股东,持股176.68万股,为新进股东。博时医疗保健混合A(050026)位居 第九大流通股东,持股1 ...
普瑞眼科8月28日获融资买入1640.88万元,融资余额9407.71万元
Xin Lang Cai Jing· 2025-08-29 02:05
Core Viewpoint - The financial performance of Purui Eye Hospital Group shows mixed results, with a slight increase in revenue but a significant decrease in net profit, indicating potential challenges in profitability despite stable revenue growth [2][3]. Group 1: Financial Performance - As of June 30, 2025, Purui Eye Hospital achieved a revenue of 1.459 billion yuan, representing a year-on-year growth of 2.74% [2]. - The net profit attributable to shareholders for the same period was 14.67 million yuan, reflecting a substantial decline of 66.12% compared to the previous year [2]. - Cumulative cash dividends distributed since the company's A-share listing amount to 74.51 million yuan [3]. Group 2: Shareholder and Market Activity - As of August 28, 2023, the total number of shareholders for Purui Eye Hospital reached 10,600, an increase of 6.24% from the previous period [2]. - The average number of circulating shares per shareholder is 6,647, which is a decrease of 5.87% from the previous period [2]. - On August 28, 2023, the financing balance for Purui Eye Hospital was 94.61 million yuan, accounting for 1.47% of its market capitalization, indicating a low financing level compared to the past year [1]. Group 3: Institutional Holdings - As of June 30, 2025, the third-largest circulating shareholder is Rongtong Health Industry Flexible Allocation Mixed A/B, holding 2.5925 million shares, an increase of 692,400 shares from the previous period [3]. - Yuanxin Yongfeng Ju You A is a new entrant among the top ten circulating shareholders, holding 1.7668 million shares [3]. - The tenth-largest circulating shareholder, ICBC Medical Care Stock, reduced its holdings by 90,000 shares compared to the previous period [3].